Literature DB >> 2430698

In vitro transformation of primary rat tracheal epithelial cells by 5-azacytidine.

C Walker, P Nettesheim.   

Abstract

The ability of the hypomethylating agent 5-azacytidine to transform normal primary rat tracheal epithelial cells was determined. A single 24-h exposure to 5-azacytidine resulted in the transformation of rat tracheal epithelial cells at concentrations of the cytosine analogue ranging from 1 to 4 microM. Doses of 5-azacytidine that produced these enhanced growth transformants were nonmutagenic as measured by the induction of 6-thioguanine or ouabain resistance. In addition, the hypomethylating agent 5-azadeoxycytidine also transformed primary rat tracheal epithelial cells, whereas 6-azacytidine, a cytosine analogue which does not induce DNA hypomethylation, did not. Enhanced growth transformants resulting from 5-azacytidine exposure continued to progress in the absence of further treatment to give rise to variants with indefinite growth capacity which ultimately became neoplastic. These results indicate that hypomethylating agents can transform normal cells and suggest that changes in DNA methylation may occur during the initial stages of neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430698

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Capture and characterization of 5-aza-2'-deoxycytidine-treated C3H/10T1/2 cells prior to transformation.

Authors:  S Rainier; A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

2.  Sudden outbreak of a leukemia-like lesion in female CBA mice after repeated injections of 5-azacytidine.

Authors:  A Luz; A B Murray
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  Epigenetic regulation of prostate cancer.

Authors:  Suyin P Chin; Joanne L Dickinson; Adele F Holloway
Journal:  Clin Epigenetics       Date:  2011-06-14       Impact factor: 6.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.